Oregon Public Employees Retirement Fund Seres Therapeutics, Inc. Transaction History

Oregon Public Employees Retirement Fund

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Jul 25, 2022	SELL	$2.7 - $7.62 $241,039 - $680,267	-89,274 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$23.25 - $37.73 $2.08 Million - $3.37 Million	89,274 New	89,274 $2.19 Million

40.5M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $95.5M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.